日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamics

肿瘤抑制因子 TMEM127 的缺失通过破坏膜动力学来驱动 RET 介导的转化

Timothy J Walker, Eduardo Reyes-Alvarez, Brandy D Hyndman, Michael G Sugiyama, Larissa C B Oliveira, Aisha N Rekab, Mathieu J F Crupi, Rebecca Cabral-Dias, Qianjin Guo, Patricia L M Dahia, Douglas S Richardson, Costin N Antonescu, Lois M Mulligan

High throughput screen identifies lysosomal acid phosphatase 2 (ACP2) to regulate IFN-1 responses to potentiate oncolytic VSV∆51 activity

高通量筛选鉴定出溶酶体酸性磷酸酶2 (ACP2) 可调节IFN-1反应,从而增强溶瘤病毒VSV∆51的活性。

Boaz Wong,Rayanna Birtch,Anabel Bergeron,Kristy Ng,Glib Maznyi,Marcus Spinelli,Andrew Chen,Anne Landry,Mathieu J F Crupi,Rozanne Arulanandam,Carolina S Ilkow,Jean-Simon Diallo

Loss of Tumour Suppressor TMEM127 Drives RET-mediated Transformation Through Disrupted Membrane Dynamics

肿瘤抑制因子 TMEM127 的缺失通过破坏膜动力学推动 RET 介导的转化

Timothy J Walker, Eduardo Reyes-Alvarez, Brandy D Hyndman, Michael G Sugiyama, Larissa C B Oliveira, Aisha N Rekab, Mathieu J F Crupi, Rebecca Cabral-Dias, Qianjin Guo, Patricia L M Dahia, Douglas S Richardson, Costin N Antonescu, Lois M Mulligan

Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies

合成病毒学方法可提高溶瘤病毒疗法的安全性和有效性

Taha Azad #, Reza Rezaei #, Ragunath Singaravelu, Adrian Pelin, Stephen Boulton, Julia Petryk, Kemal Alper Onsu, Nikolas T Martin, Victoria Hoskin, Mina Ghahremani, Marie Marotel, Ricardo Marius, Xiaohong He, Mathieu J F Crupi, Huy-Dung Hoang, Abolfazl Nik-Akhtar, Mahsa Ahmadi, Nika Kooshki Zamani, 

Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus

用于评估曲妥珠单抗-美坦新联合溶瘤弹状病毒治疗的人类HER2+转移性乳腺癌同源小鼠模型

Zaid Taha ,Mathieu J F Crupi ,Nouf Alluqmani ,Faiha Fareez ,Kristy Ng ,Judy Sobh ,Emily Lee ,Andrew Chen ,Max Thomson ,Marcus M Spinelli ,Carolina S Ilkow ,John C Bell ,Rozanne Arulanandam ,Jean-Simon Diallo

Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment

脂肪酸转运蛋白抑制通过调节肿瘤微环境的脂质,使乳腺癌和卵巢癌对溶瘤病毒疗法更加敏感。

Abera Surendran,Monire Jamalkhah,Joanna Poutou,Rayanna Birtch,Christine Lawson,Jaahnavi Dave,Mathieu J F Crupi,Justin Mayer,Victoria Taylor,Julia Petryk,Christiano Tanese de Souza,Neil Moodie,Jacob Lecompte Billingsley,Bradley Austin,Nicole Cormack,Natalie Blamey,Reza Rezaei,Curtis W McCloskey,Emily E F Fekete,Harsimrat K Birdi,Serge Neault,Taylor R Jamieson,Brenna Wylie,Sarah Tucker,Taha Azad,Barbara Vanderhyden,Lee-Hwa Tai,John C Bell,Carolina S Ilkow

CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX

CRISPR 介导的痘病毒载体快速武装可以轻松生成新型免疫治疗药物 STINGPOX

Jack T Whelan, Ragunath Singaravelu, Fuan Wang, Adrian Pelin, Levi A Tamming, Giuseppe Pugliese, Nikolas T Martin, Mathieu J F Crupi, Julia Petryk, Bradley Austin, Xiaohong He, Ricardo Marius, Jessie Duong, Carter Jones, Emily E F Fekete, Nouf Alluqmani, Andrew Chen, Stephen Boulton, Michael S Huh, 

Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral development

抑制由 cAMP 直接激活的交换蛋白作为广谱抗病毒开发的策略

Stephen Boulton, Mathieu J F Crupi, Siddharth Singh, Madalina E Carter-Timofte, Taha Azad, Bailey C Organ, Xiaohong He, Rida Gill, Serge Neault, Taylor Jamieson, Jaahnavi Dave, Naziia Kurmasheva, Bradley Austin, Julia Petryk, Ragunath Singaravelu, Ben Zhen Huang, Noah Franco, Kaaviya Babu, Robin J P

A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection

AT 细胞靶向多抗原疫苗可产生强大的细胞和体液免疫力,抵抗 SARS-CoV-2 感染

Stephen Boulton, Joanna Poutou, Rida Gill, Nouf Alluqmani, Xiaohong He, Ragunath Singaravelu, Mathieu J F Crupi, Julia Petryk, Bradley Austin, Leonard Angka, Zaid Taha, Iris Teo, Siddarth Singh, Rameen Jamil, Ricardo Marius, Nikolas Martin, Taylor Jamieson, Taha Azad, Jean-Simon Diallo, Carolina S I

Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy

基于 Split-T7 聚合酶设计雷帕霉素类似物诱导基因开关,以调节溶瘤病毒驱动的肿瘤定位 IL-12 的产生,用于抗癌免疫治疗

Nikolas T Martin, Mathieu J F Crupi, Zaid Taha, Joanna Poutou, Jack T Whelan, Sydney Vallati, Julia Petryk, Ricardo Marius, Bradley Austin, Taha Azad, Mason Boulanger, Tamara Burgess, Ilson Sanders, Camille Victoor, Bryan C Dickinson, Jean-Simon Diallo, Carolina S Ilkow, John C Bell